Yahoo
FOSTER CITY, Calif., April 14, 2025--Mirum’s LIVMARLI Now FDA Approved in Tablet Formulation
Yahoo
FOSTER CITY, Calif., April 10, 2025--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo
Avidity Biosciences (RNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Yahoo
Mirum Pharmaceuticals (MIRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Finnhub
FOSTER CITY - Mirum Pharmaceuticals, Inc. today announced that its partner, Takeda Pharmaceutical Company Limited, has received approval by the Japanese Ministry of Health, Labour, and Welfare for...
Yahoo
FOSTER CITY, Calif., March 27, 2025--LIVMARLI Now Approved in Japan for ALGS and PFIC
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBIL | -0.07% | $738.60M | 0.15% |
IBTJ | -0.12% | $639.15M | 0.07% |
IBTI | -0.20% | $979.39M | 0.07% |
UNG | -0.22% | $374.88M | 1.06% |
IEI | 0.25% | $15.96B | 0.15% |
VGIT | 0.26% | $31.53B | 0.04% |
SCHO | -0.28% | $10.85B | 0.03% |
YEAR | -0.44% | $1.34B | 0.25% |
TUR | 0.72% | $150.60M | 0.59% |
ICSH | 0.73% | $5.69B | 0.08% |
DFNM | 0.76% | $1.52B | 0.17% |
BSMW | -0.81% | $101.91M | 0.18% |
IBTM | 0.81% | $313.32M | 0.07% |
BSSX | -0.87% | $74.57M | 0.18% |
JPLD | 0.94% | $1.16B | 0.24% |
BSV | 0.95% | $35.77B | 0.03% |
UUP | 0.95% | $243.64M | 0.77% |
VRIG | 0.96% | $1.30B | 0.3% |
SGOV | 1.08% | $42.70B | 0.09% |
USDU | 1.12% | $217.39M | 0.5% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PAC | -0.03% | $8.02B | +13.22% | 0.00% |
CYD | 0.16% | $626.36M | +83.81% | 2.42% |
MDLZ | -0.22% | $86.87B | +0.54% | 2.74% |
QXO | -0.24% | $5.70B | -83.55% | 0.00% |
CVGW | 0.24% | $427.54M | -1.92% | 2.94% |
DXCM | -0.26% | $25.93B | -51.42% | 0.00% |
KO | 0.28% | $307.40B | +22.56% | 2.76% |
CPSH | 0.29% | $21.93M | -14.20% | 0.00% |
MEG | 0.30% | $467.96M | -69.77% | 0.00% |
GME | -0.32% | $11.80B | +145.13% | 0.00% |
GILT | 0.33% | $340.39M | +6.61% | 0.00% |
OCFT | 0.37% | $222.60M | +210.26% | 0.00% |
DRD | -0.38% | $1.39B | +91.01% | 1.78% |
EW | -0.39% | $40.65B | -23.13% | 0.00% |
VSA | -0.42% | $3.58M | -81.08% | 0.00% |
ICL | 0.42% | $8.10B | +32.77% | 2.97% |
FMS | -0.43% | $14.07B | +30.40% | 2.62% |
PRA | 0.44% | $1.19B | +75.72% | 0.00% |
HSIC | -0.48% | $8.00B | -9.22% | 0.00% |
MPW | -0.55% | $3.17B | +32.33% | 10.02% |
Double maintains 3 strategies that include MIRM - Mirum Pharmaceuticals, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 41.31% | $4.65B | 0.35% |
PBE | 37.85% | $204.38M | 0.58% |
IBB | 36.80% | $5.06B | 0.45% |
GNOM | 36.05% | $43.88M | 0.5% |
KJUL | 34.89% | $128.70M | 0.79% |
BETZ | 34.65% | $66.81M | 0.75% |
IWO | 34.48% | $10.07B | 0.24% |
KJAN | 33.81% | $292.10M | 0.79% |
VTWO | 33.64% | $10.25B | 0.07% |
IWM | 33.62% | $57.88B | 0.19% |
IWC | 33.53% | $709.33M | 0.6% |
VBK | 33.47% | $15.96B | 0.07% |
PTH | 33.34% | $97.93M | 0.6% |
FBT | 33.30% | $964.65M | 0.56% |
SCHA | 33.26% | $14.62B | 0.04% |
ESML | 33.25% | $1.59B | 0.17% |
SMLF | 33.20% | $1.58B | 0.15% |
VXF | 32.91% | $18.28B | 0.05% |
NUSC | 32.87% | $996.11M | 0.31% |
VB | 32.87% | $53.91B | 0.05% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -26.44% | $195.31M | 0.85% |
TAIL | -24.66% | $103.42M | 0.59% |
BTAL | -23.61% | $422.73M | 1.43% |
IVOL | -10.39% | $487.86M | 1.02% |
XHLF | -9.55% | $1.07B | 0.03% |
GBIL | -9.04% | $6.27B | 0.12% |
IBMO | -8.66% | $504.09M | 0.18% |
KCCA | -7.84% | $94.69M | 0.87% |
TBLL | -6.91% | $2.47B | 0.08% |
FXY | -6.68% | $745.99M | 0.4% |
FTSD | -5.83% | $219.33M | 0.25% |
ULST | -5.38% | $624.22M | 0.2% |
WEAT | -4.95% | $120.91M | 0.28% |
SPTS | -4.40% | $6.24B | 0.03% |
CMBS | -3.89% | $424.61M | 0.25% |
XONE | -3.80% | $626.56M | 0.03% |
VGSH | -3.58% | $22.93B | 0.03% |
IBTG | -3.39% | $1.84B | 0.07% |
SHYM | -3.26% | $306.46M | 0.35% |
BILZ | -3.19% | $807.76M | 0.14% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AVPT | 35.22% | $2.95B | +84.16% | 0.00% |
WHD | 34.88% | $2.48B | -28.82% | 1.37% |
RARE | 34.58% | $3.21B | -27.36% | 0.00% |
MCS | 34.23% | $495.65M | +21.88% | 1.72% |
SPXC | 33.32% | $6.18B | +9.36% | 0.00% |
CRNX | 33.18% | $2.71B | -34.72% | 0.00% |
ROIV | 32.91% | $7.04B | -9.87% | 0.00% |
SRAD | 32.78% | $6.72B | +113.33% | 0.00% |
CHDN | 32.70% | $7.53B | -15.09% | 0.40% |
ARWR | 32.62% | $1.62B | -52.27% | 0.00% |
ZNTL | 32.26% | $88.33M | -90.83% | 0.00% |
TFIN | 32.22% | $1.15B | -35.22% | 0.00% |
KRYS | 32.21% | $4.77B | -4.96% | 0.00% |
CPS | 32.16% | $212.51M | -29.88% | 0.00% |
XPOF | 32.10% | $248.03M | -48.92% | 0.00% |
HXL | 31.86% | $4.17B | -17.07% | 1.17% |
COGT | 31.84% | $485.00M | -34.56% | 0.00% |
CAKE | 31.83% | $2.38B | +37.76% | 2.30% |
MORN | 31.74% | $11.69B | -10.63% | 0.62% |
PRKS | 31.63% | $2.30B | -21.01% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
OVID | -21.68% | $19.90M | -91.25% | 0.00% |
AMCX | -17.64% | $265.25M | -43.19% | 0.00% |
CMTL | -10.35% | $39.62M | -41.94% | 0.00% |
RILY | -8.49% | $90.58M | -86.04% | 16.35% |
HSY | -8.07% | $33.55B | -10.84% | 3.29% |
STG | -7.94% | $24.92M | -45.45% | 0.00% |
PDCO | -7.78% | $2.73B | +21.41% | 2.49% |
K | -7.60% | $28.41B | +48.48% | 2.76% |
FMTO | -7.35% | $299.10K | -99.74% | 0.00% |
VZ | -7.20% | $184.54B | +10.10% | 6.17% |
VSTA | -6.81% | $389.63M | +27.56% | 0.00% |
KR | -6.61% | $45.09B | +23.59% | 1.84% |
WBA | -6.40% | $9.32B | -39.61% | 6.90% |
ZCMD | -5.90% | $33.03M | -20.12% | 0.00% |
T | -5.86% | $192.30B | +64.26% | 4.16% |
IMNN | -5.70% | $12.43M | -46.54% | 0.00% |
MKTX | -5.62% | $8.36B | +4.14% | 1.34% |
AGL | -4.66% | $2.34B | +14.75% | 0.00% |
CME | -4.02% | $94.25B | +24.84% | 4.04% |
CCRN | -4.01% | $470.20M | -18.39% | 0.00% |
Current Value
$39.901 Year Return
Current Value
$39.901 Year Return